Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Aspire Biopharma Holdings, Inc. (ASBP) had Non-Operating Income/Expense of $-0.70M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.00M |
|
$-1.85M |
|
$0.00M |
|
$0.00M |
|
$1.15M |
|
$-1.15M |
|
|
Non-Operating Income/Expense |
$-0.70M |
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.15M |
|
$-1.15M |
|
49.53M |
|
49.53M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$2.40M |
|
-- |
|
-- |
|
$2.40M |
|
$13.86M |
|
-- |
|
$0.01M |
|
$13.87M |
|
$-11.47M |
|
$-11.47M |
|
$-11.47M |
|
49.53M |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
-- |
|
$5.94M |
|
$0.00M |
|
$1.95M |
|
$1.94M |
|
$14.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.17 |
|
-- |
|
-- |
|
-- |
|
-0.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.00M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.03 |
|
-- |
|
-- |
|
16.14% |
|
16.14% |
|
-77.00% |
|
16.14% |
|
$-0.23 |
|
$-0.08 |
|
$-0.08 |
|